Several independent studies have reported the absence of KLF6 genetic alterations in colorectal, liver, brain and prostate cancers [100,101,102,103,104,105,106], contradicting earlier studies that showed the frequent KLF6 inactivation in these cancer types. Here, KLF6 is linked to prostate carcinoma.